BusinessAbeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis BullosaBy Nasdaq OMXMay 25, 2017, 12:10 PM UTC
BusinessAbeona Therapeutics to Present at Multiple Upcoming ConferencesBy Nasdaq OMXMay 19, 2017, 12:06 PM UTC
BusinessAbeona Therapeutics to Present at Multiple Upcoming ConferencesBy Nasdaq OMXMay 19, 2017, 12:06 PM UTC